Clinical value of circulating splicing factors in prostate cancer: SRRM1 as a novel predictive biomarker and therapeutic target.
Montero-Hidalgo AJ, Gómez-Gómez E, Galán-Cañete M, Porcel-Pastrana F, Pérez-Gómez JM, Ortega-Bellido M, Carrasco-Valiente J, Chamorro-Castillo L, Campos-Hernández JP, Rangel-Zuñiga OA, González-Serrano T, Sánchez-Sánchez R, Sarmento-Cabral A, Gahete MD, Jiménez-Vacas JM, Luque RM.
Montero-Hidalgo AJ, et al. Among authors: perez gomez jm.
Mol Ther Oncol. 2024 Nov 23;32(4):200910. doi: 10.1016/j.omton.2024.200910. eCollection 2024 Dec 19.
Mol Ther Oncol. 2024.
PMID: 39758250
Free PMC article.